Dyne Therapeutics, Inc. - 10-Q Filing
Dyne Therapeutics reports Q3 financial results including research and development expenses and details regarding Hercules Loan Agreement tranches.
Tickers: $DYN
Dyne Therapeutics reports Q3 financial results including research and development expenses and details regarding Hercules Loan Agreement tranches.
Tickers: $DYN